EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Uterine Ultramover in Cervical Cancer Radiation Therapy: Retroversion and the Rationale for Online Adaptive Planning

Elena Riggenbach, Tony Tadic, Kathy Han

Practical Radiation Oncology · 2026-11 · 16 (6) · 535-536

DOI: 10.1016/j.prro.2026.04.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical Radiation Oncology, 2026-11. Verfasst von Elena Riggenbach und 2 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Radiation Medicine Program, Toronto, Canada; Departments of R…. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Varian Medical Systems, Merck, Swiss Cancer Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uterine motion is a recognized challenge in cervical cancer radiotherapy, significantly affecting target coverage and organ-at-risk exposure.1 Retroversion — a posterior tilt of the uterine axis toward the sacral hollow, arising from an increased cervicovaginal and/or uterocervical angle — compounds the geometric uncertainty further.2 In patients with a retroverted uterus, one has to anticipate that anatomical changes throughout treatment — whether driven by bladder and rectal filling or treatment-related tumor response — may flip the uterus, as illustrated by the two pre-treatment imaging sessions in Figure 1 capturing both anatomical extremes.

Autor:innen und Institutionen

  • Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Radiation Medicine Program, Toronto, Canada; Departments of Radiation Oncology, University of Toronto, Toronto, Canada.
  • Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Radiation Medicine Program, Toronto, Canada; Departments of Radiation Oncology, University of Toronto, Toronto, Canada. Electronic…

Förderung

  • Varian Medical Systems
  • Merck
  • Swiss Cancer Research

Zitieren

APA

Riggenbach, E., Tadic, T., & Han, K. (2026). Uterine Ultramover in Cervical Cancer Radiation Therapy: Retroversion and the Rationale for Online Adaptive Planning. Practical Radiation Oncology, 16(6), 535-536. https://doi.org/10.1016/j.prro.2026.04.011

Vancouver

Riggenbach E, Tadic T, Han K. Uterine Ultramover in Cervical Cancer Radiation Therapy: Retroversion and the Rationale for Online Adaptive Planning. Practical Radiation Oncology. 2026;16(6):535-536. doi:10.1016/j.prro.2026.04.011

BibTeX
@article{Riggenbach2026,
  author = {Riggenbach, Elena and Tadic, Tony and Han, Kathy},
  title = {Uterine Ultramover in Cervical Cancer Radiation Therapy: Retroversion and the Rationale for Online Adaptive Planning},
  journal = {Practical Radiation Oncology},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {535--536},
  doi = {10.1016/j.prro.2026.04.011}
}
Kostenlos starten →